• 30 April 2018

    BMS forms collaboration to study lupus drug

    Bristol-Myers Squibb (BMS) has partnered with Lupus Research Alliance and Lupus Therapeutics to evaluate a new investigational therapy, BMS-986165, for lupus erythematosus.